Predictive Oncology Inc. (NASDAQ: POAI) Streamlines Capital, Simplifies Balance Sheet through Debt Exchange
POAI CEO exchanges $2.1 promissory note for shares of common stock Agreement enables Predictive Oncology to strengthen balance sheet, simplify capital structure at critical juncture in quest to commercialize highly valuable database POAI cancels outstanding debt of $2,115,000 in aggregate principal amount of 12% promissory note Predictive Oncology Inc. (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery, has entered into an agreement with its CEO to exchange a $2.1 million promissory note for newly issued equity (http://ibn.fm/lzYPh). The strategic move demonstrates the confidence CEO Dr. Carl Schwartz has in the growing company. “This agreement enables…